Clinical Trial Update: KPT-330 to Treat Poorly Differentiated Lung and Gastroenteropancreatic Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for KPT-330 targeting poorly differentiated lung and gastroenteropancreatic tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma Neuroendocrine

Drugs mentioned

• KPT-330

Snippet

Sponsor: Gabrail Cancer Center Research | Conditions: Carcinoma, Neuroendocrine | Phase 2 | Status: COMPLETED